 CAMBRIDGE, Mass., Aug. 05, 2022 GLOBE NEWSWIRE -- Evelo Biosciences, Inc. Nasdaq: EVLO, a clinical stage biotechnology company developing a novel platform of orally delivered medicines acting on the small intestinal axis, SINTAX, today announced that it will host a conference call and live webcast at 7:30 a.m. ET on Thursday, August 11, 2022, to report its second quarter 2022 financial results. 